MC
ASXC

Moors & Cabot’s Asensus Surgical, Inc. ASXC Stock Holding History

Moors & Cabot’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-769
Closed -$6K – 716
2019
Q3 		$6K Buy
+769
New +$10.5K ﹤0.01% 653
2018
Q4 		– Sell
-1,031
Closed -$78K – 585
2018
Q3 		$78K Buy
+1,031
New +$69.8K 0.01% 567

Other funds holding ASXC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Moors & Cabot's ASXC Position: Q4 2019 in Review

Moors & Cabot sold out of Asensus Surgical, Inc. (ASXC) in Q4 2019, closing a stake of 769 shares — an estimated $6K sold.

Moors & Cabot first reported a position in ASXC in Q3 2018 and held it in 2 quarters. The position peaked at $78K in Q3 2018. 81 funds tracked by Wall St. Rank hold ASXC as of Q4 2019.

  • Moors & Cabot reported no remaining Asensus Surgical, Inc. position as of Q4 2019 after selling out during the quarter.
  • Moors & Cabot sold 769 Asensus Surgical, Inc. shares in Q4 2019, an estimated $6K.
  • Moors & Cabot first reported a position in Asensus Surgical, Inc. in Q3 2018 and held it in 2 quarters.
  • Moors & Cabot's Asensus Surgical, Inc. position peaked at $78K in Q3 2018.
  • 81 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q4 2019.

Based on Moors & Cabot's 13F filing for Q4 2019, filed 28 Jan 2020.